Calumet Inc (CLMT): Next-Year EPS Estimate 195.14%
As of 2026-10-16, Calumet Inc (CLMT) has a next-year EPS growth estimate of 195.14%. Featured in 4 EPS revision reports, most recently on 2026-08-17.
On 2026-10-08, analyst consensus for CLMT's next-year EPS growth shifted from 198.28% to 195.14% — a negative change of 3.14 percentage points. The revised estimate has been sustained across 9 subsequent trading sessions. Current-year growth is projected at -483.34%.
What's Driving This
CLMT's rise has been driven primarily by a structural upgrade to next-year EPS growth estimates, which analysts raised to 188.76% on 2026-09-01 and have since pushed to 195.14%, indicating continued upward momentum. The revision followed Q2 2026 results citing record Specialties performance, alongside an upsized revolving credit facility, a final $34 million DOE loan draw, and a capital-efficient Montana Renewables SAF expansion. These operational and financing developments plausibly underpin the improved earnings outlook.
Generated 2026-10-16 from news as of 2026-10-16
Current Snapshot
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- EPS growth next year
- 195.14%
- EPS growth this year
- -483.34%
- EPS next quarter (est)
- $1.59
- Last price
- $57.75
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-10-16 | 195.14% | -483.34% | $1.59 | $57.75 |
| 2026-10-15 | 195.14% | -483.34% | $1.59 | $58.24 |
| 2026-10-14 | 195.14% | -483.34% | $1.59 | $57.53 |
| 2026-10-13 | 195.14% | -483.34% | $1.59 | $58.59 |
| 2026-10-12 | 195.14% | -483.34% | $1.59 | $57.17 |
| 2026-10-11 | 195.14% | -483.34% | $1.59 | $56.42 |
| 2026-10-10 | 195.14% | -483.34% | $1.59 | $56.42 |
| 2026-10-09 | 195.14% | -483.34% | $1.59 | $56.42 |
| 2026-10-08 | 195.14% | -483.34% | $1.59 | $57.75 |
| 2026-10-07 | 198.28% | -476.16% | $1.55 | $56.29 |
| 2026-10-06 | 198.28% | -476.16% | $1.55 | $56.21 |
| 2026-10-05 | 198.28% | -476.16% | $1.55 | $56.03 |
| 2026-10-04 | 198.28% | -476.16% | $1.55 | $55.28 |
| 2026-10-03 | 198.28% | -476.16% | $1.55 | $55.28 |
| 2026-10-02 | 198.28% | -476.16% | $1.55 | $55.28 |
| 2026-10-01 | 198.28% | -476.16% | $1.55 | $53.72 |
| 2026-09-30 | 198.28% | -476.16% | $1.55 | $52.38 |
| 2026-09-29 | 198.28% | -476.16% | $1.55 | $53.23 |
| 2026-09-28 | 198.28% | -476.16% | $1.55 | $52.61 |
| 2026-09-27 | 198.28% | -476.16% | $1.55 | $53.65 |
| 2026-09-25 | 198.28% | -476.16% | $1.55 | $53.65 |
| 2026-09-24 | 198.28% | -476.16% | $1.55 | $53.85 |
| 2026-09-23 | 198.28% | -476.16% | $1.55 | $54.38 |
| 2026-09-22 | 198.28% | -476.16% | $1.55 | $56.42 |
| 2026-09-21 | 198.28% | -476.16% | $1.55 | $58.12 |
| 2026-09-20 | 198.28% | -476.16% | $1.55 | $59.00 |
| 2026-09-18 | 198.28% | -476.16% | $1.55 | $59.00 |
| 2026-09-17 | 198.28% | -476.16% | $1.55 | $59.05 |
| 2026-09-16 | 198.28% | -476.16% | $1.55 | $58.01 |
| 2026-09-15 | 198.28% | -476.16% | $1.55 | $57.55 |
Reports Featuring CLMT
- 2026-08-17
SNDK Soars 45.9% After EPS Revision, AI Memory Boom Fuels Rally
- 2026-08-13
SHAZ Surges 44.6% on AI Capacity Expansion; SNDK, ACB, CLMT, NYXH Follow
- 2026-07-21
FWRD Leads EPS Revision Surge with 26.7% Gain; AEHR, RCEL Follow
- 2026-07-20
RCEL leads with 27.9% gain on EPS revision; other healthcare stocks follow
Recent News
- Calumet Upsizes Senior Secured Revolving Credit Facility and Receives Final $34 Million Draw under the DOE LoanPR Newswire
- Calumet Provides Update After Latest U.S. EPA Small Refinery Exemption DecisionPR Newswire
- Montana Renewables Announces Innovative, Capital-Efficient Expansion to 200 Million Gallons of Sustainable Aviation FuelPR Newswire
- Calumet Inc (CLMT) (Q2 2026) Earnings Call Highlights: Record Specialties Performance and ...GuruFocus.com
- Calumet Inc (CLMT) (Q2 2026) Earnings Call Highlights: Record Specialties Performance and ...GuruFocus.com
- Calumet Reports Second Quarter 2026 ResultsPR Newswire
- Calumet Reports Second Quarter 2026 ResultsPR Newswire
- Calumet Announces Board Member Will Not Stand for Re-ElectionPR Newswire
Screen Performance
Aggregate stats across all 2082 tickers our top-EPS-revision screen has flagged over the past 198 days.
- Median return since detection
- -3.0%
- % of tickers in the green
- 43%
- Median return on winners
- +21.5%
- Large revisions captured
- 1886
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Calumet Inc's next-year EPS growth estimate?▾
As of 2026-10-16, Calumet Inc (CLMT) has a next-year EPS growth estimate of 195.14%, based on analyst consensus.
When was the latest EPS estimate revision for CLMT?▾
The most recent revision occurred on 2026-10-08, when analysts adjusted the next-year EPS growth estimate from 198.28% to 195.14%.
What sector and industry does Calumet Inc belong to?▾
Calumet Inc operates in the Basic Materials sector, specifically the Specialty Chemicals industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. CLMT appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Calumet Inc (CLMT) appears here because it was detected by our daily top-EPS-revision-performer screen.